source
- FDA approves Merck’s first oral PCSK9 inhibitor, marking a first for the drug classThe U.S. Food and Drug Administration has granted approval to Merck for its oral PCSK9 inhibitor, the first drug of this type to receive such clearance. The approval represents a milestone because…
- Eli Lilly to buy psychedelics biotech AtaiBeckley for $2.8 billionEli Lilly announced it will acquire AtaiBeckley, a biotech focused on psychedelic therapies for mental health, for an upfront cash payment of $2.8 billion. The purchase adds a new dimension to Lil…